ViroPharma, Inc. (NASDAQ:VPHM)

CAPS Rating: 4 out of 5

A biopharmaceutical company dedicated to the development and commercialization of products that address serious infectious diseases, with a focus on products used by physician specialists or in hospital settings.

Recs

0
Player Avatar LuckyShad (71.99) Submitted: 8/18/2010 1:38:55 PM : Outperform Start Price: $13.54 VPHM Score: +28.72

CAPS=5/88

Featured Broker Partners


Advertisement